Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,623.78
+39.232.48%
Number of Gainers:3
Number of Losers:4
Number of Flat:- -
PE:- -
High:1,631.64
Open:1,583.40
Low:1,582.57
Close:1,584.55
Volume:35.80M
Turnover:2.16B
Market Cap:1.69T
Float Cap:1.63T

Loading ...

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Reuters
·
1 hour ago

Viking Therapeutics Shares Down 15% After Co Prices Upsized Stock, Convertible Offerings

THOMSON REUTERS
·
1 hour ago

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
2 hours ago

Viking Therapeutics, - Offering Size Increased to $275 Mln Common Stock and $225 Mln Notes

THOMSON REUTERS
·
3 hours ago

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
4 hours ago

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
4 hours ago

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
4 hours ago

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Deep News
·
6 hours ago

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Dow Jones
·
6 hours ago

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS
·
6 hours ago

Leerink Partners Remains a Hold on Amgen (AMGN)

TIPRANKS
·
9 hours ago

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
13 hours ago

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
13 hours ago

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

Stock News
·
14 hours ago

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

TIPRANKS
·
17 hours ago

Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Reuters
·
18 hours ago

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

THOMSON REUTERS
·
18 hours ago

Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032

THOMSON REUTERS
·
18 hours ago

Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes

THOMSON REUTERS
·
18 hours ago

Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
18 hours ago